{"disease":{"id":"treatment-of-bronchial-asthma-transient-or-intermittent-in-nature-when-oral-therapy-is-not-appropriate","name":"Treatment of bronchial asthma, transient or intermittent in nature, when oral therapy is not appropriate","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"ephedrine-hydrochloride-3-mg-ml","indication_name":"Treatment of bronchial asthma, transient or intermittent in nature, when oral therapy is not appropriate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ephedrine Hydrochloride 3 MG/ML","company_name":"University Hospital, Ghent","drug_phase":"marketed","molecular_target":"α-adrenergic receptors (α1, α2) and β-adrenergic receptors (β1, β2); sympathetic nerve terminals","drug_class":"Sympathomimetic amine; adrenergic agonist","quality_score":55,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}